Drug Shortage Report for PROPOFOL
Report ID | 90084 |
Drug Identification Number | 02468336 |
Brand name | PROPOFOL |
Common or Proper name | Propofol |
Company Name | BAXTER CORPORATION |
Market Status | CANCELLED POST MARKET |
Active Ingredient(s) | PROPOFOL |
Strength(s) | 10MG |
Dosage form(s) | EMULSION |
Route of administration | INTRAVENOUS |
Packaging size | 20 mL |
ATC code | N01AX |
ATC description | ANESTHETICS, GENERAL |
Reason for shortage | Demand increase for the drug. |
Anticipated start date | 2019-07-29 |
Actual start date | 2019-07-29 |
Estimated end date | 2019-08-26 |
Actual end date | 2019-08-26 |
Shortage status | Resolved |
Updated date | 2019-08-27 |
Company comments | Product on allocation; For questions or concerns contact Baxter customer care (1.888.719.9955) or your local representative. |
Health Canada comments | |
Tier 3 Status | No |
Contact Address | 7125 MISSISSAUGA ROAD MISSISSAUGA, ONTARIO CANADA L5N 0C2 |
Company contact information |
Version History
Click on "Compare" below to view the full report history and compare to other versions.
Version Number | Date Updated | Language | |
---|---|---|---|
v1 | 2019-07-29 | English | Compare |
v2 | 2019-07-29 | French | Compare |
v3 | 2019-07-30 | English | Compare |
v4 | 2019-08-19 | English | Compare |
v5 | 2019-08-19 | French | Compare |
v6 | 2019-08-26 | English | Compare |
v7 | 2019-08-26 | French | Compare |
v8 | 2019-08-27 | English | Compare |
Showing 1 to 8 of 8